Elevated Cellular Uptake of Succinimide- and Glucose-Modified Liposomes for Blood-Brain Barrier Transfer and Glioblastoma Therapy

• Published in: Biomedicines Vol. 12; no. 9; p. 2135
• Main Authors: Lubitz, Larissa J, Haffner, Moritz P, Rieger, Harden, Leneweit, Gero
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 20.09.2024; MDPI
• Subjects: Blood-brain barrier; Brain cancer; Brain tumors; Cancer; Cancer therapies; Care and treatment; Cholesterol; Dextrose; drug targeting; Endothelial cells; Enzymes; Ethylenediaminetetraacetic acid; Glioblastoma; Glioblastoma multiforme; Glioma; Glucose; Ligands; Lipids; Liposomes; Medical prognosis; Molecular weight; Nanoparticles; Nervous system; Peptides; Permeability; Polyethylene glycol; Pore size; Succinimide; Tumors; Germany; United Kingdom > UK; United States > US; drug targeting; glucose; blood–brain barrier; glioblastoma; liposomes
• ISSN: 2227-9059; 2227-9059
• DOI: 10.3390/biomedicines12092135

The uptake of four liposomal formulations was tested with the murine endothelial cell line bEnd.3 and the human glioblastoma cell line U-87 MG. All formulations were composed of DPPC, cholesterol, 5 mol% of mPEG (2000 Da, conjugated to DSPE), and the dye DiD. Three of the formulations had an additional PEG chain (nominally 5000 Da, conjugated to DSPE) with either succinimide (NHS), glucose (PEG-bound at C-6), or 4-aminophenyl β-D-glucopyranoside (bound at C-1) as ligands at the distal end. Measuring the uptake kinetics at 1 h and 3 h for liposomal incubation concentrations of 100 µM, 500 µM, and 1000 µM, we calculated the liposomal uptake saturation and the saturation half-time . We show that only succinimide has an elevated uptake in bEnd.3 cells, which makes it a very promising and so far largely unexplored candidate for BBB transfer and brain cancer therapies. Half-times are uniform at low concentrations but diversify for high concentrations for bEnd.3 cells. Contrary, U-87 MG cells show almost identical saturations for all three ligands, making a uniform uptake mechanism likely. Only mPEG liposomes stay at 60% of the saturation for ligand-coated liposomes. Half-times are diverse at low concentrations but unify at high concentrations for U-87 MG cells.